Novel and Selective TLR7 Antagonists among the Imidazo[1,2-a]pyrazines, Imidazo[1,5-a]quinoxalines, and Pyrazolo[1,5-a]quinoxalines Series-Reference-Cited by-同舟云学术

Novel and Selective TLR7 Antagonists among the Imidazo[1,2-a]pyrazines, Imidazo[1,5-a]quinoxalines, and Pyrazolo[1,5-a]quinoxalines Series

Published:2019-07-08 Issue:15 Volume:62 Page:7015-7031
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Bou Karroum Nour¹²,Moarbess Georges²,Guichou Jean-François³,Bonnet Pierre-Antoine¹^ORCID,Patinote Cindy¹,Bouharoun-Tayoun Hasnaa⁴,Chamat Soulaima⁴⁵,Cuq Pierre¹,Diab-Assaf Mona²,Kassab Issam²,Deleuze-Masquefa Carine¹

Affiliation:

1. Institut des Biomolécules Max Mousseron (IBMM), UMR 5247 F16, CNRS, Université de Montpellier, Faculté de Pharmacie, 15 avenue Charles Flahault, BP 14491, Montpellier 34093 Cedex 5, France

2. Tumorigenèse et Pharmacologie Antitumorale, Lebanese University, EDST, BP 90656, Fanar Jdeideh 1202, Lebanon

3. CNRS, UMR 5048, INSERM, U105, Université de Montpellier, Centre de Biochimie Structurale, Montpellier F-34090, France

4. Laboratory of Immunology and Vector-Borne Diseases, Faculty of Public Health, Lebanese University, Fanar Jdeideh 1202, Lebanon

5. Faculty of Medical Sciences, Lebanese University, Hadath 1500, Lebanon

Funder

Universit? Libanaise

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b00411